Latest News

The new generic formulation matches the composition of Celgene’s original Pomalyst medication and comes in four different strengths: 1mg, 2mg, 3mg, and 4mg.

Cervical cancer remains the deadliest malignancy affecting women in Sierra Leone and the second most common cancer among those aged 15 to 49, causing over 500 new cases and approximately 370 deaths annually.

The new manufacturing hub represents a core strategic priority for PharmaEssentia as the company works to strengthen its supply chain, increase production flexibility, and diversify its geographic footprint.

The Japanese pharmaceutical giant expects the transaction to conclude during the first quarter of fiscal 2026, subject to standard regulatory conditions.

While no human cases have emerged since 2020, the country maintains its classification as endemic due to persistent animal infections.

The surgery combined breast augmentation with bilateral brachioplasty—a procedure that removes excess skin from both arms—to restore natural contours and enhance symmetry.

The EMA will now proceed with a final decision, potentially clearing the way for global distribution of this combination immunization.

Developed jointly by the Drugs for Neglected Diseases initiative and Sanofi, Acoziborole Winthrop represents a substantial improvement over existing therapies, which require either a 10-day oral regimen or combined injections and oral medications for advanced cases.

The tabletting facility in Athlone represents a cornerstone of Novo Nordisk’s long-term strategy to strengthen its presence in Ireland and enhance its global manufacturing footprint.

The SEEG procedure operates as a sophisticated mapping tool, allowing neurosurgeons to precisely identify the exact regions of the brain responsible for triggering seizures.